United States · Funded startup

Who invested in Dracen Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$2.3Mraised across 1 round since 2023, from 1 source

Latest round
Debt, $2.3MAug 2023
Investors
1
See who backed them

The rounds

  1. Aug 2023
    Debt$2.3M

    Source recordedSEC filing: $2.3M sold, first sale Jun 2023

Founders and team

From the SEC filings it signed: 2 on the team.

  • Asher M. RubinExecutive Officeri
  • Dennis M. BilskiExecutive Officeri

On the board, as filediDrew M. PardollJonathan M. Leff

Everyone who backed them

DeerfieldVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Dracen Pharmaceuticals

Who invested in Dracen Pharmaceuticals?

Dracen Pharmaceuticals's investors include Deerfield.

How much has Dracen Pharmaceuticals raised?

Dracen Pharmaceuticals has raised $2.3M across 1 round since 2023.

When did Dracen Pharmaceuticals last raise?

Dracen Pharmaceuticals's most recent round was a Debt of $2.3M in Aug 2023.

What was Dracen Pharmaceuticals's biggest round?

Its most recent round, $2.3M in Aug 2023, is also its largest on record.

Who backed Dracen Pharmaceuticals first?

Dracen Pharmaceuticals's first round on record, in Aug 2023, was backed by Deerfield.

What stage is Dracen Pharmaceuticals at?

Dracen Pharmaceuticals's latest named round is a Debt, in Aug 2023.

Where is Dracen Pharmaceuticals based?

Dracen Pharmaceuticals is based in the United States.

Companies like Dracen Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.